Skip to main content
Skip to main content
University of California San Francisco
UCSF
|
About UCSF
|
Search UCSF
Home
Technology Disclosure
MENU
Services
Innovation & Entrepreneurship
HealthTech Commercialization
Funding for Translational Technology
Teams
Engagement & Opportunity Development
Technology Licensing
Strategic Alliances
Business Affairs & Strategic Partnerships
Catalyst
Resources
Policies
Forms
Outgoing Material Transfer
Industry Statistics
Startup Resources
Translational Opportunities
Jobs & Internships
Partnering with Industry FAQs
Protecting Your Idea
Technology Disclosure
About
Contact
Success Stories
Events
Teams
Media
News
Newsletters
Podcasts
Videos
Services
Teams
Resources
About
Media
Home
About
UCSF Startups
Medical Therapeutics
UCSF Startups and Innovation in Therapeutics
Medical Therapeutics
Cancer
AtlasMedx
eFFECTOR Therapeutics
Exelixis
Fortis Therapeutics
Halozyme Therapeutics
K-Gen
KSQ Therapeutics
Metkine Therapeutics
Nalo Therapeutics
OncoSynergy
Orphagen Pharmaceuticals
Pionyr Immunotherapeutics
Principia Biopharma
Prosetta Biosciences
Telo Therapeutics
Vivace Therapeutics
Cardiovascular Diseases
Catalyst Biosciences
InCarda Therapeutics
Cell Therapy
Cell Design Labs (acquired by Gilead)
Central Nervous System
Epiodyne
MedGenesis Therapeutix
Mitokinin
Neuraltus Pharmaceuticals
Neurona Therapeutics
PharmatrophiX
Principia Biopharma
Prosetta Biosciences
Voyager Therapeutics
Hearing Disorders
Jacaranda Biosciences
Infectious Diseases
Prosetta Biosciences
TheraBiol
Metabolic Disorders
Empire Biotechnologies
Ophthalmology
Orphan Diseases
Epygenix Therapeutics
Orphagen Pharmaceuticals
Respiratory
Aer Therapeutics